Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India flag India · Delayed Price · Currency is INR
4,599.20
-12.70 (-0.28%)
May 13, 2026, 3:30 PM IST

NSE:SANOFICONR Income Statement

Millions INR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
9,3508,7847,2458,331
Revenue Growth (YoY)
38.42%21.24%-13.04%-
Cost of Revenue
2,4752,3011,8772,291
Gross Profit
6,8756,4835,3686,041
Selling, General & Admin
1,3231,2881,2351,050
Other Operating Expenses
2,2142,1051,4271,709
Operating Expenses
3,6663,5102,7072,786
Operating Income
3,2092,9732,6613,255
Interest Expense
-21-20-39-
Interest & Investment Income
--11860
Currency Exchange Gain (Loss)
--1-
Other Non Operating Income (Expenses)
188184111.5
EBT Excluding Unusual Items
3,3763,1372,7523,317
Asset Writedown
---29-
Other Unusual Items
6666-255-27
Pretax Income
3,4423,2032,4683,290
Income Tax Expense
863802658816
Net Income
2,5792,4011,8102,474
Net Income to Common
2,5792,4011,8102,474
Net Income Growth
53.24%32.65%-26.82%-
Shares Outstanding (Basic)
23232323
Shares Outstanding (Diluted)
23232323
Shares Change (YoY)
11.48%-0.02%--
EPS (Basic)
112.03104.2778.59107.40
EPS (Diluted)
112.03104.2778.59107.40
EPS Growth
37.46%32.67%-26.82%-
Free Cash Flow
-1,6724,291-66
Free Cash Flow Per Share
-72.61186.32-2.87
Dividend Per Share
-75.00055.000-
Dividend Growth
-36.36%--
Gross Margin
73.53%73.80%74.09%72.51%
Operating Margin
34.32%33.85%36.73%39.07%
Profit Margin
27.58%27.33%24.98%29.69%
Free Cash Flow Margin
-19.04%59.23%-0.79%
EBITDA
3,3503,0902,6833,282
EBITDA Margin
35.83%35.18%37.03%39.40%
D&A For EBITDA
140.751172227
EBIT
3,2092,9732,6613,255
EBIT Margin
34.32%33.85%36.73%39.07%
Effective Tax Rate
25.07%25.04%26.66%24.81%
Revenue as Reported
9,5388,9687,3758,393
Advertising Expenses
--181-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.